Last week the talking heads all said we are only back to where we were three weeks ago... Now it's longer. Nobody thought much of the potential of a sell off because we were having a rolling correction. Well you've been rolled. Half tempted to call a bottom for the Russell... 1st to go down. 1st to go up. 10% correction complete/
Have you stopped out of Funko yet like I told you to, or are you gonna ride it down to $16.40? Ya know Stoney, back to school is an annual thing for this company. It's already priced into the forecasts. Look at a 2 year chart of Funko vs DBI... identical. DBI trades at half the multiple... $13.65 as I type.... Funko is $17.25 I say dump Funko now and buy DBI!!!! Seriously Stoney. DBI will bounce, their stores are packed. I could care less what Mrs Stoney says. Dump FNKO/Buy DBI
i'm sticking with FNKO - my kids are getting Funko NFTs for Christmas. but seriously- anyone still buying these dips? I'm waiting for a bit of upward momentum.
Is that Digital Brands Van. That stk has traded poorly before this correction. Couldn't hold a gain. This Covid scare is going to hurt mall and store traffic I'm afraid. Suddenly we are heading in the wrong direction. Or are we. FNKO is going to be fine. They are a value stk don't forget and their little dolls are cool. Alot of crossing info that I do not think is 100% accurate. 1st- Covid cases are up 100% but that's from very low levels. 6 to 12 in some town is 100%. 2nd- New mask mandate by CA has really dented confidence in recovery. 3rd- if you catch Covid after being vaccinated it's supposed to be not that serious. 4- vague report from England that I cannot track down that new cases are folks double vaccinated-- not good granted but are those new hospitalizations? If so what's going on. NVAX is up over $20 cannot be a good sign. MDRNA had just set a 52 week high... Airlines and Hotels and all of that well there never was a recovery globally it was a pipe dream from day 1. Cruise ships- add another year to all global recovery stories... But US based activities will have the numbers come earnings time. Don't bet against a Cedar Fair or Seaworld.... Casino's look stranded. Back to school story dented, Some education outfit recommended masks again for kids in schools because they cannot always get vaccines...
Perception is huge here. If the Olympics fall apart it will not be good for stocks. If they pull it off without too many athletes dropping out for Covid positive tests. That would be good for stocks.
Van you are talking about the shoe guys. Look into their buyout of Camuto it's a nightmare. Formal wear shoes and seasonal both out of favor. Deff a re opening trade and that's in trouble now. "Second and most importantly, the primary reason that we purchased Camuto was to support U.S. retail and exclusive brands and the strong sales synergies with their national brands. However, given that these products have traditionally focused on dress and seasonal products, the business is particularly challenged at the moment. With strong aversion to public gatherings and shelter-in-place mindsets, we have seen the dress and seasonal categories significantly slow, leading to weakness within Camuto." – Q2 call As a result, management has reduced future production levels by 73% for the balance of the year. Since the facts have changed, we believe Camuto has added a layer of risk to DBI that wasn’t there before the pandemic. It has also changed our view on the attractiveness of DBI as an investment. Is that coming back I don't think so. It's the Roaring Twenties right! (install laughter) but is a Rome is dying mindset if you are going to buy 1 pair of shoes it ain't going to be from DBI. Prada maybe?- EBAY most likely!
stoney have you looked to see when their next catalysts are supposed to be? i feel like it's not for a bit still (august? sept?), which was why i was swing trading it. if i have a moment i'll try to find some rough dates because i want a position ahead of it
PLXP Stoney. $19.50 on the ask. Grab it. EDIT.... Naaaaaa. Bad idea. Short it at $20 SPARTA, N.J., July 19, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products, with its lead products VAZALORE™ 325 mg and VAZALORE™ 81 mg (referred to together as “VAZALORE”), today announced that three stock-keeping units (“SKUs”) of VAZALORE, the first and only U.S. Food and Drug Administration (“FDA”) approved liquid-filled aspirin capsules, will be available in over 8,000 Walgreens stores nationwide later in August. Walgreens is a global leader in retail pharmacy. Walgreens has already inserted placeholders to reserve space on shelves for all three SKUs: VAZALORE 81 mg, 12 count; VAZALORE 81 mg, 30 count; and VAZALORE 325 mg, 30 count. “As we continue to execute on our commercial launch plans, we are delighted that Walgreens has committed to carrying all three SKUs of VAZALORE in over 8,000 of its stores throughout the country. Walgreens’ focus on health and wellbeing aligns closely with our mission to bring VAZALORE to the millions of people who can benefit from our unique aspirin therapy,” stated Natasha Giordano, Chief Executive Officer of PLx. About VAZALORE VAZALORE is an FDA-approved liquid-filled aspirin capsule that provides patients with vascular disease and diabetic patients who are candidates for aspirin therapy based on physician recommendation, with fast, reliable and predictable platelet inhibition as compared to enteric-coated aspirin. It also reduces the risk of stomach erosions and ulcers, as compared to immediate-release aspirin, common in an acute setting. To learn more about VAZALORE, please visit